CD11b agonism overcomes PDAC immunotherapy resistance
نویسندگان
چکیده
منابع مشابه
ERK inhibition overcomes acquired resistance to MEK inhibitors.
The RAS/RAF/MEK pathway is activated in more than 30% of human cancers, most commonly via mutation in the K-ras oncogene and also via mutations in BRAF. Several allosteric mitogen-activated protein/extracellular signal-regulated kinase (MEK) inhibitors, aimed at treating tumors with RAS/RAF pathway alterations, are in clinical development. However, acquired resistance to these inhibitors has be...
متن کاملSorafenib inhibits ABCG2 and overcomes irinotecan resistance--response.
We are aware that sorafenib binds to plasma proteins. At steady state, when sorafenib is orally administered at 800 mg/d, accumulation ratios are 5.7 to 6.4, indicating that it has a good distribution range. Of note, 90% of sorafenib is bound to the plasma proteins (1), but the large distribution volume indicates that this binding does not affect the body distribution. Moreover, binding to plas...
متن کاملMET inhibition overcomes radiation resistance of glioblastoma stem‐like cells
Glioblastoma (GBM) contains stem-like cells (GSCs) known to be resistant to ionizing radiation and thus responsible for therapeutic failure and rapidly lethal tumor recurrence. It is known that GSC radioresistance relies on efficient activation of the DNA damage response, but the mechanisms linking this response with the stem status are still unclear. Here, we show that the MET receptor kinase,...
متن کاملValproic acid overcomes hypoxia-induced resistance to apoptosis
Valproic acid (VPA), a histone deacetylase inhibitor (HDACi), has been shown to be an effective tool in cancer treatment. Although its ability to induce apoptosis has been described in many cancer types, the data come from experiments performed in normoxic (21% O2) conditions only. Therefore, we questioned whether VPA would be equally effective un...
متن کاملBlockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance.
UNLABELLED The transcription factor AP-1 is downstream of growth factor (GF) receptors (GFRs) and stress-related kinases, both of which are implicated in breast cancer endocrine resistance. Previously, we have suggested that acquired endocrine resistance is associated with increased activity of AP-1 in an in vivo model. In this report, we provide direct evidence for the role of AP-1 in endocrin...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Gastroenterology & Hepatology
سال: 2019
ISSN: 1759-5045,1759-5053
DOI: 10.1038/s41575-019-0191-1